| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |